Company · CIK 0001835579 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
ImageneBio, Inc. · IMA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 AForm 4 → | Aug 17, 5:00 pm EDT | Kristin YaremaChief Executive Officer, Director | 254,800 | — | — | 493,705 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 5:00 pm EDT | Yanina Grant-HuertaChief Financial Officer | 104,000 | — | — | 104,000 | — | |
| Jul 25, 2026 JMForm 4 → | Jul 28, 4:05 pm EDT | Kristin YaremaChief Executive Officer, Director | 153,505 | — | — | 238,905 | — | |
| Jul 16, 2026 SForm 4 → | Jul 20, 9:47 pm EDT | Robert B LallyPrincipal Accounting Officer | 3,196 | $5.42 | $17,334 | 55,582 | −5.44% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 AForm 4 → | Aug 17, 5:00 pm EDT | Kristin YaremaChief Executive Officer, Director | 387,200 | — | — | 250,000 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 5:00 pm EDT | Yanina Grant-HuertaChief Financial Officer | 56,000 | — | — | 56,000 | — | |
| Jul 25, 2026 JMForm 4 → | Jul 28, 4:05 pm EDT | Kristin YaremaChief Executive Officer, Director | 153,505 | — | — | 0 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 6:45 pm EDT | Jonathan Jian WangDirector | 15,600 | — | — | 15,600 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 6:45 pm EDT | Otello StampacchiaDirector | 15,600 | — | — | 15,600 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 6:45 pm EDT | Joseph P SlatteryDirector | 15,600 | — | — | 15,600 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 6:45 pm EDT | David P BonitaDirector | 15,600 | — | — | 15,600 | — |